Safety and effects of different type of intra-peritoneal implantation of sustained-releasing 5-fluorouracil in patients with gastrointestinal cancer

Bin LIANG,Zhi-ying YU,Mu-jun YIN,Qi-wei XIE,Xiao-dong YANG,Ying-jiang YE,Shan WANG

DOI: https://doi.org/10.3760/cma.j.issn.1673-4777.2013.03.031

2013-01-01

Abstract:Objective To observe the change in the 5-fluorouracil (5-FU) concentration of abdominal cavity,rate of postoperative complications and immunomodulations of the patients with gastric or colorectal cancer after intra-abdominal implantation of sustained-releasing 5-FU.Methods Forty-five selected patients who underwent open radical gastroenterological surgery were randomly divided into 3 groups (dissociated implantation group,fixed implantation group,or reference group) at the ratio of 1∶ 1∶1 according to the random number table.Routine blood test,biochemistry,systemic levels of C reactive protein (CRP) and interleukin 6 (IL-6),percentage of CD3+,CD4+,and CD8+ lymphocytes were evaluated preoperatively and on postoperative dl,d4,d7 and d10.5-FU concentration of blood or abdominal cavity drainage samples was evaluated on postoperative d1,d2,d4 and d7.Occurrence of postoperative complications was evaluated.Results The blood 5-FU concentration was below 100 ng/ml and undetectable by high performance liquid chromatography assay in both experimental groups.No differences between the 3 groups were noticed in serum levels of IL-6 on postoperative days.CRP serum levels of patients in fixed implantation group were lower than those of reference group on postoperative d4 [(60 ± 29) mg/L vs (110 ± 61) mg/L,P ＜0.05].Compared with those of reference group on postoperative dl,percentage of CD3+ and CD4+ lymphocytes was significantly depressed in the dissociated implantation group[(47 ± 11)％ vs (60 ± 13)％ and (23 ± 6)％ vs (34 ± 13) ％,respectively,P ＜ 0.05].Conclusions Different methods of intra-abdominal implantation of sustained-releasing 5-FU during radical surgery of gastrointestinal cancer has little effect on 5-FU concentrations of abdominal cavity.Maintenance of high level of 5-FU in the abdominal cavity can be obtained more than 7 days.Implantation of sustained-releasing 5-FU did not increase the rate of postoperative complications,and had negligible influence on routing blood test and liver and kidney functions.In consideration of the change of immunomodulation and inflammation parameters,fixed implantation of sustained-releasing 5-FU was preferred method of intra-peritoneal chemotherapy.